Hanseatic Management Services’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-24,549
Closed -$1.34M 433
2017
Q2
$1.34M Buy
24,549
+32
+0.1% +$1.53K 0.68% 50
2017
Q1
$1.03M Sell
24,517
-2,933
-11% -$125K 0.57% 63
2016
Q4
$1.18M Sell
27,450
-27,174
-50% -$1.1M 0.66% 56
2016
Q3
$2.25M Buy
54,624
+9,432
+21% +$395K 0.8% 45
2016
Q2
$1.8M Sell
45,192
-3,002
-6% -$108K 0.68% 46
2016
Q1
$1.62M Buy
48,194
+48,094
+48,094% +$1.5M 0.59% 72
2015
Q4
$3K Hold
100
﹤0.01% 255
2015
Q3
$3K Buy
100
+63
+170% +$1.97K ﹤0.01% 290
2015
Q2
$1K Buy
+37
New +$986 ﹤0.01% 337

Other funds holding IART

Hanseatic Management Services's IART Position: Q3 2017 in Review

Hanseatic Management Services sold out of Integra LifeSciences (IART) in Q3 2017, closing a stake of 24,549 shares — an estimated $1.34M sold.

Hanseatic Management Services first reported a position in IART in Q2 2015 and held it in 9 quarters. The position peaked at $2.25M in Q3 2016. 213 funds tracked by Wall St. Rank hold IART as of Q3 2017.

  • Hanseatic Management Services reported no remaining Integra LifeSciences position as of Q3 2017 after selling out during the quarter.
  • Hanseatic Management Services sold 24,549 Integra LifeSciences shares in Q3 2017, an estimated $1.34M.
  • Hanseatic Management Services first reported a position in Integra LifeSciences in Q2 2015 and held it in 9 quarters.
  • Hanseatic Management Services's Integra LifeSciences position peaked at $2.25M in Q3 2016.
  • 213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2017.

Based on Hanseatic Management Services's 13F filing for Q3 2017, filed 7 Nov 2017.